Medidata Unveils New Oncology & Vaccine Trial Bundles
Slice of Healthcare Team
Nov 05, 2024
Key Highlights
- New bundled solutions for oncology and vaccine clinical trials
- Focus on patient-centered endpoints and adaptive trial designs
- Accelerates decision-making and improves safety assessment
- Supports FDA guidance on diversity in clinical trials
Source: Business Wire
Notable Quote
“ Oncology and vaccine trials face significant challenges in recruiting diverse patients, ensuring rapid execution, and maintaining and monitoring patient safety. By making these new bundled capabilities readily available to customers, we can deliver a solution built on Medidata’s vast experience and expertise in these two important therapeutic areas. These bundles are designed to help customers navigate the complicated stages of these studies while advancing life-saving treatments. ”
Joseph Schmidt, Chief Operating Officer at Medidata
